These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17167831)

  • 1. Emerging therapies in gastrointestinal cancers.
    Nautiyal J; Rishi AK; Majumdar AP
    World J Gastroenterol; 2006 Dec; 12(46):7440-50. PubMed ID: 17167831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist.
    Majumdar AP
    Future Oncol; 2005 Apr; 1(2):235-45. PubMed ID: 16555995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
    Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
    Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH
    Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbB.
    Fu XH; Li J; Huang JJ; Zheng S; Zhang SZ
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1373-6. PubMed ID: 21947130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
    Graus-Porta D; Beerli RR; Hynes NE
    Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ErbB receptors in high-grade glioma.
    Berezowska S; Schlegel J
    Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer.
    Allen LF; Lenehan PF; Eiseman IA; Elliott WL; Fry DW
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):11-21. PubMed ID: 12138393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.
    Tedesco KL; Lockhart AC; Berlin JD
    Curr Treat Options Oncol; 2004 Oct; 5(5):393-403. PubMed ID: 15341677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the HER-kinase axis in cancer.
    Gross ME; Shazer RL; Agus DB
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):9-20. PubMed ID: 15052539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the EGF/HER Ligand-Receptor System in Cancer.
    Esparís-Ogando A; Montero JC; Arribas J; Ocaña A; Pandiella A
    Curr Pharm Des; 2016; 22(39):5887-5898. PubMed ID: 27426127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors.
    Cruz-López O; Conejo-García A; Núñez MC; Kimatrai M; García-Rubiño ME; Morales F; Gómez-Pérez V; Campos JM
    Curr Med Chem; 2011; 18(7):943-63. PubMed ID: 21254978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
    Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models.
    Francis DM; Huang S; Armstrong EA; Werner LR; Hullett C; Li C; Morris ZS; Swick AD; Kragh M; Lantto J; Kimple RJ; Harari PM
    Clin Cancer Res; 2016 Feb; 22(3):633-43. PubMed ID: 26420857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
    Tzahar E; Waterman H; Chen X; Levkowitz G; Karunagaran D; Lavi S; Ratzkin BJ; Yarden Y
    Mol Cell Biol; 1996 Oct; 16(10):5276-87. PubMed ID: 8816440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm.
    Boerner JL; Danielsen A; Maihle NJ
    Exp Cell Res; 2003 Mar; 284(1):111-21. PubMed ID: 12648470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
    Pellat A; Vaquero J; Fouassier L
    Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.